Website
N/ATelephone
61.2.9078.8180
Address
Suite 506, Level 5 50 Clarence Street Sydney, New South Wales (NSW) 2000
Description
Bioxyne Ltd. engages in the research, development, market and distribution of health products. It operates through the Wholesale Sales, and Direct Sales segments. The Wholesale Sales segment covers operation in United States of America (USA), and Asia. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.03
Trade Value (12mth)
AU$1,073.00
1 week
-8.33%
1 month
-8.33%
YTD
-56%
1 year
-54.17%
All time high
8.93489
EPS 3 yr Growth
55.600%
EBITDA Margin
-37.60%
Operating Cashflow
-$1m
Free Cash Flow Return
-9.90%
ROIC
-22.80%
Interest Coverage
N/A
Quick Ratio
1.90
Shares on Issue (Fully Dilluted)
1328m
HALO Sector
Industrials
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 October 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 October 13 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
31 May 23 |
Change in substantial holding
×
Change in substantial holding |
31 May 23 |
Becoming a substantial holder
×
Becoming a substantial holder |
31 July 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 January 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 August 23 |
Preliminary Final Report
×
Preliminary Final Report |
30 September 22 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
30 September 21 |
Explanatory Note to the 2021 Annual Report
×
Explanatory Note to the 2021 Annual Report |
30 September 21 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 20 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 19 |
Explanatory Note to the 2019 Annual Report
×
Explanatory Note to the 2019 Annual Report |
30 September 19 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 15 |
2015 Annual Report to Shareholders
×
2015 Annual Report to Shareholders |
30 September 14 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
30 September 08 |
Annual Report 2008
×
Annual Report 2008 |
30 November 22 |
New Constitution
×
New Constitution |
30 June 22 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
30 June 22 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
30 August 22 |
Preliminary Final Report
×
Preliminary Final Report |
29 September 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
29 September 23 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 September 16 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 October 21 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
29 October 21 |
Letter to Shareholders on Annual General Meeting
×
Letter to Shareholders on Annual General Meeting |
29 October 14 |
Notice of 2014 Annual General Meeting/Proxy Form
×
Notice of 2014 Annual General Meeting/Proxy Form |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.